Endocervical infections due to Chlamydia trachomatis remain difficult to diagnose due to the lack of an inexpensive, rapid, and accurate test. We evaluated an alternative strategy for diagnosis in which initial screening was performed with an enzyme immunoassay (Chlamydiazyme) followed by a direct fluorescent antibody (DFA) test on specimens in which the Chlamydiazyme optical density (OD) reading fell in an intermediate zone. Lowering the Chlamydiazyme OD ratio (specimen to control) used to define a positive test from 1.0 (the ratio suggested by the manufacturer) to 0.3 raised the sensitivity of Chlamydiazyme from 73 to 83%. Confirmation of those specimens having OD ratios of 0.3 to 0.99 by DFA testing increased the specificity of Chlamydiazyme from 95 to 100%. This strategy necessitated performance of the DFA test on 5% of the specimens. Lowering the cutoff OD ratio below 0.3 increased the sensitivity even further but required DFA testing on >25% of the specimens. Use of an adjusted positive cutoif value for defining positive enzyme immunoassays followed by DFA confirmation for intermediate-zone readings may be a feasible approach for some laboratories that lack cell culture facilities.
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Chlamydia trachomatis continues to be the major cause of endocervical infections in females. These infections are often asymptomatic and if undetected may progress to cause endometritis and pelvic inflammatory disease, with resulting infertility and ectopic pregnancy (10) . Thus far, a national screening program for chlamydial infection has not been implemented, in part because of the lack of a diagnostic test that is easy to perform, highly accurate, and inexpensive. In experienced laboratories, cell culture remains the most sensitive and specific test for chlamydial infection but is expensive and not widely available (1) . Direct fluorescent antibody (DFA) testing and enzyme immunoassays (EIAs) have been introduced more recently. The sensitivity and specificity of DFA testing can be excellent in experienced hands, but the test performs less well in laboratories without DFA experience (7) . Additionally, the DFA test is labor intensive and not well suited to screening large numbers of specimens. In contrast, EIAs are easily automated and thus excellent for large-scale screening. Unfortunately, the sensitivity of EIA has often been significantly less than that of culture, and its specificity has been suboptimal because of cross-reactive antigens (6, 11, 12 sure to STD, and 87% for those who underwent routine screening. There was no significant difference in the sensitivity of Chlamydiazyme among specimens from women who reported using oral contraceptives versus those from women who reported using any other method of birth control. Collection of the EIA swab after the initial swab for culture did appear to increase the number of false-negative Chlamydiazyme results (3.4% in the first half of the study versus 1.6% in the second half). The initial specificity of EIA was 99.8%; it rose to 100%, however, when the blocking assay was used to confirm all initially positive results.
The relationship between the number of inclusion-forming units in culture and the sensitivity of Chlamydiazyme is shown in Fig. 1 . Greater numbers of inclusion-forming units were correlated with higher sensitivity of Chlamydiazyme (P < 0.0001 by x2 test for linear trend).
The DFA test had an overall sensitivity of 90% compared with culture (Table 2 ) and did not vary significantly by clinic (STD clinic, 92%; FP-B, 89%; and FP-A, 86%). Approximately 2% of the DFA slides collected at each clinic were uninterpretable. When examined by reason for visit, the sensitivity was 92% for patients reporting symptoms, 82% for those reporting exposure to STD, and 88% for those who underwent routine screening. There were two false-positive DFA tests (specificity = 99.8%).
Use of DFA as confirmation for EIA intermediate-zone results. In an attempt to improve the sensitivity of the EIA, the OD reading defining a positive result was lowered. Table   3 demonstrates the range of sensitivity and specificity for the assay when various OD readings were chosen to define an intermediate zone. Although the sensitivity was markedly improved by lowering the OD ratio value to 0.1 or 0.2, the specificity at these levels was such that .27.5% of specimens required DFA confirmation. At an OD ratio of 0.3, confirmatory DFA tests were required for 50 specimens (5%) and seven additional chlamydial infections were diagnosed. (3) . Second, a uniformly accepted definition of cervicitis has yet to be established (2, 5, 9) . Except for the most obvious cases in which there is overt endocervical mucopus, an accurate diagnosis requires the aid of a Chlamydia detection method. Third, no ideal detection method currently is available. In laboratories without access to cell culture, we evaluated the possibility that the DFA test could serve as a suitable confirmatory test for an EIA. We hypothesized that the EIA could be interpreted with an OD range above which the result is reliably positive and a lower OD limit below which the result is reliably negative and that the DFA test could then be applied as a confirmatory assay only for those specimens for which the EIA result fell between the upper and lower OD limits. In this scenario, a clinician could collect a single specimen on a swab to inoculate both a DFA slide and the EIA transport medium. The laboratory would perform the EIA on all specimens but would perform the DFA test only on those for which the EIA result fell within the defined OD range. Thus, the labor-intensive and morecostly assay would be performed on a minority of the specimens, with the cost prorated over the entire population tested. The DFA slide could be saved for several days, permitting the clinician to request this assay for additional specimens if the EIA results were believed to be inconsistent with clinical or epidemiologic information.
Our study increased the sensitivity from 73 to 83%, the specificity predictably fell from 100 to 95%, and this necessitated interpretation of 5% of the DFA slides. Since the volume of specimens that a given laboratory receives for processing is variable, the number of DFA slides which could be comfortably interpreted would also be variable. In a high-volume laboratory, 5% of slides may be all that can be read, whereas Chlamydiazyme, which is often negative in specimens with few inclusion-forming units. Given this hypothesis, one might also expect to find false-positive DFA tests. Two were found; we suspect that more were not identified because the DFA test and culture are close to one another in sensitivity. Thus, when the culture was falsely negative because of a small number of inclusion-forming units which were at that time nonviable, these same specimens were those that had few elementary bodies and may not have been identified as positive.
False-positive results were previously a major concern when EIA was used for screening low-prevalence populations, even when the cutoff suggested by the manufacturer was used. The addition of a blocking assay to confirm positive results for Chlamydiazyme eliminated false-positives in our study. Others have noted similar improvement in specificity by using the blocking assay (Howard et al., Int. Soc. Sex. Transm. Dis. Res. 1989). False-positive results may be partly the result of improper specimen collection. Excessive amounts of mucus appear to cause false-positive readings, which can be verified as true-negatives by use of the blocking assay (personal observation). It is not known if the blocking assay could serve to differentiate true-positives from false-positives within an intermediate-zone reading. The use of cytobrushes to collect endocervical specimens might also help to increase the sensitivity of EIA by increasing the amount of antigen present (4, 8) .
In summary, we have demonstrated the sensitivity of the Chlamydiazyme EIA for endocervical specimens to be 73% in a large group of symptomatic and asymptomatic women when it was compared with a sensitive culture system. The addition of the Chlamydiazyme blocking assay eliminated false-positive results. Using the strategy of screening all patients by EIA at lower OD cutoff values resulted in increased EIA sensitivity with decreased specificity. Addition of DFA to the intermediate-zone specimens returned the specificity for the combined tests to 100%, indicating that the DFA test can be a reliable confirmatory method for intermediate-zone Chlamydiazyme readings. The usefulness of this strategy in a given setting will depend upon available laboratory facilities and the prevalence of infection in the population tested. Further experience with this approach at another testing site would be of interest to assess its feasibility.
